Drug trial shows promise for deadly neurological disorder
A small clinical trial shows that a drug called cyclodextrin slows progression of the rare, deadly disorder Niemann-Pick type C, according to a new study from Washington University School of Medicine in St. Louis and the National Institutes of Health (NIH). First author Daniel S. Ory, MD, (right) speaks with co-authors Rohini Sidhu, (far left) a staff scientist, and Xuntian Jiang, PhD, an assistant professor of medicine. (Robert Boston/Washington University School of Medicine)
